James George Robinson - Net Worth and Insider Trading
James George Robinson Net Worth
The estimated net worth of James George Robinson is at least $1 Million dollars as of 2024-09-20. James George Robinson is the Director, 10% Owner of Nymox Pharmaceutical Corp and owns about 4,782,065 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $1 Million. James George Robinson is also the Director, 10% Owner of Allied Corp and owns about 4,782,065 shares of Allied Corp (ALID) stock worth over $225,713. Details can be seen in James George Robinson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James George Robinson has not made any transactions after 2023-04-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James George Robinson
James George Robinson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James George Robinson owns 2 companies in total, including Nymox Pharmaceutical Corp (NYMXF) , and Allied Corp (ALID) .
Click here to see the complete history of James George Robinson’s form 4 insider trades.
Insider Ownership Summary of James George Robinson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2023-04-27 | director |
| ALID | Allied Corp | 2023-04-27 | director & 10 percent owner |
James George Robinson Latest Holdings Summary
James George Robinson currently owns a total of 2 stocks. Among these stocks, James George Robinson owns 4,782,065 shares of Nymox Pharmaceutical Corp (NYMXF) as of April 27, 2023, with a value of $1 Million and a weighting of 82.26%. James George Robinson also owns 4,782,065 shares of Allied Corp (ALID) as of April 27, 2023, with a value of $225,713 and a weighting of 17.74%.
Latest Holdings of James George Robinson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2023-04-27 | 4,782,065 | 0.22 | 1,046,316 |
| ALID | Allied Corp | 2023-04-27 | 4,782,065 | 0.05 | 225,713 |
Holding Weightings of James George Robinson
James George Robinson Form 4 Trading Tracker
According to the SEC Form 4 filings, James George Robinson has made a total of 4 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Nymox Pharmaceutical Corp is the acquisition of 80,000 shares on April 27, 2023, which cost James George Robinson around $36,800.
According to the SEC Form 4 filings, James George Robinson has made a total of 1 transactions in Allied Corp (ALID) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allied Corp is the acquisition of 80,000 shares on April 27, 2023, which cost James George Robinson around $36,800.
Insider Trading History of James George Robinson
- 1
James George Robinson Trading Performance
GuruFocus tracks the stock performance after each of James George Robinson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James George Robinson is 14.17%. GuruFocus also compares James George Robinson's trading performance to market benchmark return within the same time period. The performance of stocks bought by James George Robinson within 3 months outperforms 59 times out of 87 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James George Robinson's insider trading performs compared to the benchmark.
Performance of James George Robinson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.44 | | | | | |
| Relative Return to S&P 500(%) | 0.47 | | | | | |
James George Robinson Ownership Network
James George Robinson Owned Company Details
What does Nymox Pharmaceutical Corp do?
Who are the key executives at Nymox Pharmaceutical Corp?
James George Robinson is the director of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include Chief Financial Officer Erik Danielsen , director & 10 percent owner & CEO Paul Averback , and director & General Counsel Randall J Lanham .
Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary
Over the past 18 months, James George Robinson made 2 insider transaction in Nymox Pharmaceutical Corp (NYMXF) with a net purchase of 120,000.
In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 120,000 shares were bought by its insiders, resulting in a net purchase of 120,000 shares.
Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nymox Pharmaceutical Corp Insider Transactions
James George Robinson Mailing Address
Above is the net worth, insider trading, and ownership report for James George Robinson. You might contact James George Robinson via mailing address: 10 East Lee Street, Suite 2705, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
